Breaking News Instant updates and real-time market news.

PEAK

Healthpeak

$35.65 /

-1.465 (-3.95%)

04:55
02/26/20
02/26
04:55
02/26/20
04:55

Healthpeak management to meet with RBC Capital

Meeting to be held in New York on February 26 hosted by RBC Capital.

  • 26

    Feb

  • 02

    Mar

PEAK Healthpeak
$35.65 /

-1.465 (-3.95%)

01/16/20
Ventas upgraded to Buy from Hold at Jefferies
12/19/19 Mizuho
Healthpeak initiated with a Buy at Mizuho

TODAY'S FREE FLY STORIES

Upgrade
Spin Master upgraded to Outperform from Sector Perform at RBC Capital » 21:46
03/02/21
03/02
21:46
03/02/21
21:46
SNMSF

Spin Master

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNMSF Spin Master
$0.00 /

+ (+0.00%)

07:47 Today Stifel
Spin Master upgraded to Buy from Hold at Stifel
05:32 Today Stifel
Spin Master upgraded to Buy from Hold at Stifel
01/25/21 CIBC
Spin Master price target lowered to C$33 from C$35 at CIBC
12/10/20 CIBC
Spin Master upgraded to Outperformer from Neutral at CIBC
SNMSF Spin Master
$0.00 /

+ (+0.00%)

Downgrade
Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital » 21:45
03/02/21
03/02
21:45
03/02/21
21:45
RKT

Rocket Companies

$41.70 /

+17.4 (+71.60%)

RBC Capital analyst…

RBC Capital analyst Daniel Perlin downgraded Rocket Companies to Sector Perform from Outperform with an unchanged price target of $30. The stock close Tuesday up $17.30 to $41.60. The risk/reward is "more balanced" following the stock's 71% rally today and 109% rise since last week's Q4 results, Perlin tells investors in a research note. The analyst believes the risk/reward "skews to the downside in the near term." Mortgage mortgage demand is expected to continue but this is now reflected in the stock, says Perlin.

ShowHide Related Items >><<
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

15:36 Today Wells Fargo
Wells says Rocket Companies Q4 results 'not good enough to support' today's move
01/19/21 JPMorgan
JPMorgan double downgrades Rocket on more cautious mortgage stance
01/19/21 JPMorgan
Rocket Companies downgraded to Underweight from Overweight at JPMorgan
12/17/20 Keefe Bruyette
Rocket Companies downgraded to Underperform at Keefe Bruyette
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

  • 06
    Aug
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

Syndicate
Orchid Island Capital 8M share Spot Secondary priced at $5.55 » 20:49
03/02/21
03/02
20:49
03/02/21
20:49
ORC

Orchid Island Capital

$5.80 /

+0.025 (+0.43%)

The deal priced at low…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

10/30/20 Ladenburg
Orchid Island Capital upgraded to Buy from Neutral at Ladenburg
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

  • 03
    Mar
  • 21
    Jan
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

Syndicate
Orchid Island Capital 8M share Spot Secondary priced at $5.55 » 20:49
03/02/21
03/02
20:49
03/02/21
20:49
ORC

Orchid Island Capital

$5.80 /

+0.025 (+0.43%)

JPMorgan is acting as…

JPMorgan is acting as sole book running manager for the offering.

ShowHide Related Items >><<
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

10/30/20 Ladenburg
Orchid Island Capital upgraded to Buy from Neutral at Ladenburg
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

  • 03
    Mar
  • 21
    Jan
ORC Orchid Island Capital
$5.80 /

+0.025 (+0.43%)

Syndicate
Morphic 3.5M share Secondary priced at $70.00 » 20:27
03/02/21
03/02
20:27
03/02/21
20:27
MORF

Morphic

$70.99 /

-13.82 (-16.30%)

The deal size was…

The deal size was increased to $245M from $200M and priced below the last closing price of $71.06. Jefferies, Cowen, BMO Capital and RBC Capital are acting as joint book running managers for the offering.

ShowHide Related Items >><<
MORF Morphic
$70.99 /

-13.82 (-16.30%)

MORF Morphic
$70.99 /

-13.82 (-16.30%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
MORF Morphic
$70.99 /

-13.82 (-16.30%)

  • 03
    Mar
MORF Morphic
$70.99 /

-13.82 (-16.30%)

Conference/Events
Digi International participates in a conference call with Piper Sandler » 20:05
03/02/21
03/02
20:05
03/02/21
20:05
DGII

Digi International

$23.50 /

-0.92 (-3.77%)

Group investor conference…

Group investor conference call to discuss the follow-on offering will be held on March 3 at 11 am hosted by Piper Sandler.

ShowHide Related Items >><<
DGII Digi International
$23.50 /

-0.92 (-3.77%)

DGII Digi International
$23.50 /

-0.92 (-3.77%)

02/04/21 Roth Capital
Digi International price target raised to $29 from $22 at Roth Capital
02/04/21 Lake Street
Digi International price target raised to $25 from $21 at Lake Street
02/04/21 Craig-Hallum
Digi International price target raised to $28 from $22 at Craig-Hallum
01/07/21 Sidoti
Digi International downgraded to Neutral from Buy at Sidoti
DGII Digi International
$23.50 /

-0.92 (-3.77%)

  • 04
    Mar
DGII Digi International
$23.50 /

-0.92 (-3.77%)

Conference/Events
Nurix Therapeutics participates in a conference call with JPMorgan » 20:03
03/02/21
03/02
20:03
03/02/21
20:03
NRIX

Nurix Therapeutics

$35.87 /

-0.305 (-0.84%)

Group investor conference…

Group investor conference call to discuss the follow-on offering will be held on March 3 at 11 am hosted by JPMorgan.

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$35.87 /

-0.305 (-0.84%)

NRIX Nurix Therapeutics
$35.87 /

-0.305 (-0.84%)

02/17/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
02/16/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
01/29/21 JPMorgan
Nurix Therapeutics price target raised to $56 from $34 at JPMorgan
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
NRIX Nurix Therapeutics
$35.87 /

-0.305 (-0.84%)

  • 05
    Mar
  • 24
    Jul
Upgrade
Sage Group upgraded to Neutral from Sell at Goldman Sachs » 19:41
03/02/21
03/02
19:41
03/02/21
19:41
SGPYY

Sage Group

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Gautam Pillai upgraded Sage Group to Neutral from Sell with an unchanged 575 GBp price target. The analyst says that the rating change is driven by the stock's underperformance, and while he remains cautious around the company's revenue trajectory since the management's investments over the last few years have not yet led to sustained top-line growth, Sage Group's business has proved to be "more resilient than expected". Pillai adds that with U.K. economy reopening soon, he sees an improvement in the company's end-market conditions.

ShowHide Related Items >><<
SGPYY Sage Group
$0.00 /

+ (+0.00%)

SGPYY Sage Group
$0.00 /

+ (+0.00%)

02/19/21 Credit Suisse
Sage Group price target raised to 547 GBp from 500 GBp at Credit Suisse
01/25/21 UBS
Sage Group upgraded to Neutral from Sell at UBS
01/22/21 Credit Suisse
Sage Group price target lowered to 500 GBp from 530 GBp at Credit Suisse
01/22/21 Peel Hunt
Sage Group initiated with a Buy at Peel Hunt
Syndicate
Magnolia Oil & Gas 17M share Spot Secondary priced at $10.50 » 19:33
03/02/21
03/02
19:33
03/02/21
19:33
MGY

Magnolia Oil & Gas

$11.84 /

-0.23 (-1.91%)

The deal prices at low…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGY Magnolia Oil & Gas
$11.84 /

-0.23 (-1.91%)

MGY Magnolia Oil & Gas
$11.84 /

-0.23 (-1.91%)

11/30/20 MKM Partners
Magnolia Oil & Gas downgraded to Neutral from Buy at MKM Partners
11/30/20 MKM Partners
Magnolia Oil & Gas downgraded to Neutral from Buy at MKM Partners
11/18/20 Piper Sandler
Magnolia Oil & Gas price target raised to $6 from $5 at Piper Sandler
11/06/20 Northland
Magnolia Oil & Gas upgraded to Outperform from Market Perform at Northland
MGY Magnolia Oil & Gas
$11.84 /

-0.23 (-1.91%)

  • 03
    Mar
General news
Export Prices data reported. » 19:32
03/02/21
03/02
19:32
03/02/21
19:32

February Export Prices at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Import Prices data reported. » 19:32
03/02/21
03/02
19:32
03/02/21
19:32

February Import Prices at…

February Import Prices at % .

On The Fly
Fly Intel: After-Hours Movers » 19:16
03/02/21
03/02
19:16
03/02/21
19:16
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

, AMBA

Ambarella

$113.78 /

-4.91 (-4.14%)

, QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

, LYFT

Lyft

$57.06 /

-0.26 (-0.45%)

, FUBO

FuboTV

$41.96 /

+3.24 (+8.37%)

, BGS

B&G Foods

$30.44 /

-0.36 (-1.17%)

, GO

Grocery Outlet

$36.12 /

+0.19 (+0.53%)

, VEC

Vectrus

$55.59 /

+0.89 (+1.63%)

, ROST

Ross Stores

$117.75 /

-2.63 (-2.18%)

, NVEE

NV5 Global

$102.47 /

-2.59 (-2.47%)

, REAL

RealReal

$26.70 /

-1.48 (-5.25%)

, RVMD

Revolution Medicines

$44.36 /

-1.57 (-3.42%)

, JWN

Nordstrom

$37.45 /

-0.5 (-1.32%)

, URBN

Urban Outfitters

$33.75 /

-0.4 (-1.17%)

, ARNA

Arena Pharmaceuticals

$76.67 /

-3.44 (-4.29%)

, SSYS

Stratasys

$32.27 /

-4.12 (-11.32%)

, ICAD

iCAD

$18.88 /

-0.3 (-1.56%)

, ABNB

Airbnb

$189.68 /

-6.16 (-3.15%)

Check out this evening's…

ShowHide Related Items >><<
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/15/20 Morgan Stanley
Maravai Lifesciences initiated with an Overweight at Morgan Stanley
12/15/20 Baird
Baird starts Maravai Lifesciences at Outperform with $31 price target
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
LYFT Lyft
$57.06 /

-0.26 (-0.45%)

02/11/21 KeyBanc
Uber price target raised to $75 from $63 at KeyBanc
02/11/21 Needham
Needham transfers coverage on Lyft, raises price target $70 from $50
02/10/21 DA Davidson
Lyft price target raised to $66 from $58 at DA Davidson
02/10/21 Jefferies
Lyft price target raised to $75 from $70 at Jefferies
FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

02/01/21 Wedbush
FuboTV price target raised to $50 from $40 at Wedbush
01/21/21 Barrington
FuboTV initiated with an Outperform at Barrington
01/19/21 LightShed Partners
FuboTV price target lowered to $6.50 from $8 at LightShed Partners
01/12/21 Roth Capital
FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
01/05/21 Credit Suisse
B&G Foods downgraded to Underperform from Neutral at Credit Suisse
07/28/20 Seaport Global
B&G Foods initiated with a Neutral at Seaport Global
06/12/20
Fly Intel: Top five analyst initiations
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

11/18/20 Berenberg
Grocery Outlet initiated with a Buy at Berenberg
11/11/20 DA Davidson
Grocery Outlet price target lowered to $50 from $53 at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

05/19/20 B. Riley Securities
B. Riley FBR sees path for Vectrus shares to top $70
03/05/20 B. Riley Securities
Vectrus price target raised to $60 from $55 at B. Riley FBR
03/04/20 Noble Capital
Vectrus upgraded to Outperform from Market Perform at Noble Capital
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

01/21/21 Deutsche Bank
Ross Stores price target raised to $129 from $123 at Deutsche Bank
01/04/21 JPMorgan
Ross Stores price target raised to $128 from $125 at JPMorgan
11/20/20 MKM Partners
Ross Stores price target raised to $124 from $105 at MKM Partners
11/20/20 Loop Capital
Ross Stores price target raised to $130 from $110 at Loop Capital
NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
08/24/20
Fly Intel: Top five analyst upgrades
08/24/20 Sidoti
Sidoti upgrades NV5 Global to Buy following pullback
REAL RealReal
$26.70 /

-1.48 (-5.25%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 BTIG
RealReal price target raised to $32 from $27 at BTIG
02/23/21 Cowen
RealReal price target raised to $29 from $18 at Cowen
02/23/21 Raymond James
RealReal downgraded to Market Perform from Outperform at Raymond James
RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

02/16/21 JPMorgan
Nordstrom price target raised to $40 from $34 at JPMorgan
02/10/21 Gordon Haskett
Nordstrom upgraded to Buy from Hold at Gordon Haskett
01/21/21 Deutsche Bank
Nordstrom price target raised to $43 from $24 at Deutsche Bank
01/14/21 Credit Suisse
Nordstrom price target raised to $39 from $26 at Credit Suisse
URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

02/26/21 Deutsche Bank
Urban Outfitters named short-term investment idea at Deutsche Bank
02/10/21 RBC Capital
Urban Outfitters price target raised to $30 from $28 at RBC Capital
01/21/21 Deutsche Bank
Urban Outfitters price target raised to $32 from $31 at Deutsche Bank
01/14/21
Fly Intel: Top five analyst downgrades
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

01/28/21 JonesTrading
Arena Pharmaceuticals initiated with a Buy at JonesTrading
11/19/20 SMBC Nikko
Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko
11/10/20 RBC Capital
Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital
11/02/20 JPMorgan
Arena Pharmaceuticals price target raised to $90 from $71 at JPMorgan
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
ICAD iCAD
$18.88 /

-0.3 (-1.56%)

02/26/21 B. Riley Securities
iCAD price target raised to $23 from $18 at B. Riley Securities
02/25/21 Oppenheimer
iCAD initiated with an Outperform at Oppenheimer
02/25/21 Craig-Hallum
iCAD price target raised to $22 from $15 at Craig-Hallum
02/25/21 Lake Street
iCAD price target raised to $21 from $17 at Lake Street
ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

02/26/21 HSBC
Airbnb price target raised to $224 from $220 at HSBC
02/26/21 Jefferies
Airbnb price target raised to $210 from $170 at Jefferies
02/26/21 DA Davidson
Airbnb price target raised to $210 from $172 at DA Davidson
02/26/21 Needham
Airbnb represents 'best way to play travel recovery', says Needham
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

  • 03
    Mar
  • 03
    Mar
  • 04
    Feb
  • 04
    Feb
  • 30
    Dec
  • 10
    Dec
  • 20
    Nov
  • 08
    Oct
  • 13
    Aug
  • 07
    Aug
  • 09
    Jul
  • 28
    May
  • 23
    Apr
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

Syndicate
Indus Realty Trust 1.75M share Secondary priced at $60.00 » 19:01
03/02/21
03/02
19:01
03/02/21
19:01
INDT

Indus Realty Trust

$60.50 /

-1.5 (-2.42%)

The deal priced below the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INDT Indus Realty Trust
$60.50 /

-1.5 (-2.42%)

  • 03
    Mar
Hot Stocks
SPDR Gold Shares holdings rise to 1,087.12MT from 1,084.50MT » 18:57
03/02/21
03/02
18:57
03/02/21
18:57
GLD

SPDR Gold Shares

$162.40 /

+0.85 (+0.53%)

This is the first…

This is the first increase in holdings since February 4th.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$162.40 /

+0.85 (+0.53%)

GLD SPDR Gold Shares
$162.40 /

+0.85 (+0.53%)

GLD SPDR Gold Shares
$162.40 /

+0.85 (+0.53%)

GLD SPDR Gold Shares
$162.40 /

+0.85 (+0.53%)

Syndicate
Autohome announces 27.26M share offering of ordinary shares » 18:49
03/02/21
03/02
18:49
03/02/21
18:49
ATHM

Autohome

$118.01 /

+1.59 (+1.37%)

Autohome announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATHM Autohome
$118.01 /

+1.59 (+1.37%)

ATHM Autohome
$118.01 /

+1.59 (+1.37%)

02/03/21 Macquarie
Autohome price target raised to $109 from $95 at Macquarie
02/03/21 HSBC
Autohome price target raised to $137 from $113 at HSBC
02/03/21 Benchmark
Autohome upgraded to Buy from Hold at Benchmark
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
ATHM Autohome
$118.01 /

+1.59 (+1.37%)

ATHM Autohome
$118.01 /

+1.59 (+1.37%)

Upgrade
Rapid7 upgraded to Overweight from Neutral at Piper Sandler » 18:43
03/02/21
03/02
18:43
03/02/21
18:43
RPD

Rapid7

$79.21 /

-2.07 (-2.55%)

Piper Sandler analyst Rob…

Piper Sandler analyst Rob Owens upgraded Rapid7 to Overweight from Neutral with a $100 price target.

ShowHide Related Items >><<
RPD Rapid7
$79.21 /

-2.07 (-2.55%)

RPD Rapid7
$79.21 /

-2.07 (-2.55%)

02/17/21 Stifel
Rapid7 resumed with a Buy at Stifel
02/10/21 Morgan Stanley
Morgan Stanley downgrades Qualys to Underweight on growth and margin pressures
02/10/21 RBC Capital
Rapid7 price target raised to $110 from $105 at RBC Capital
01/27/21 Truist
Rapid7 price target raised to $95 from $72 at Truist
RPD Rapid7
$79.21 /

-2.07 (-2.55%)

RPD Rapid7
$79.21 /

-2.07 (-2.55%)

Recommendations
Target price target lowered to $200 from $220 at Baird » 18:41
03/02/21
03/02
18:41
03/02/21
18:41
TGT

Target

$173.40 /

-12.72 (-6.83%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

02/09/21 Jefferies
Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Stifel
Target upgraded to Buy from Hold at Stifel
01/14/21 DA Davidson
Target price target raised to $229 from $208 at DA Davidson
TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

Hot Stocks
Welltower and ProMedica announce partnership expansion » 18:41
03/02/21
03/02
18:41
03/02/21
18:41
WELL

Welltower

$68.68 /

+0.15 (+0.22%)

, GEN

Genesis Healthcare

$0.82 /

+0.0034 (+0.42%)

ProMedica and Welltower…

ProMedica and Welltower (WELL) announced two transactions to strengthen and expand their strong existing partnership while maintaining an unwavering focus on patient care and clinical outcomes. The transactions serve to enhance the quality of the Welltower/ProMedica joint venture portfolio and position it for continued growth going forward. First, the JV will divest a 25 property portfolio of non-strategic skilled nursing facilities for $265M. The properties, which were acquired through the formation of the Welltower/ProMedica partnership in 2018, are in eight states and have an average age of 41 years. Second, nine PowerBack rehabilitation facilities, operated by Genesis HealthCare (GEN), will be contributed into Welltower's JV with ProMedica and master leased to ProMedica. The properties are mostly purpose-built state-of-the-art rehabilitation facilities, with numerous amenities. Reimbursements are received primarily from Medicare and commercial insurance providers.

ShowHide Related Items >><<
WELL Welltower
$68.68 /

+0.15 (+0.22%)

GEN Genesis Healthcare
$0.82 /

+0.0034 (+0.42%)

WELL Welltower
$68.68 /

+0.15 (+0.22%)

02/09/21 Mizuho
Welltower price target raised to $60 from $57 at Mizuho
01/26/21 Deutsche Bank
Welltower price target lowered to $67 from $71 at Deutsche Bank
01/11/21 BMO Capital
Brookdale data supports cautious view on senior housing, says BMO
01/07/21 BMO Capital
Welltower downgraded to Underperform from Market Perform at BMO Capital
GEN Genesis Healthcare
$0.82 /

+0.0034 (+0.42%)

01/25/21 Credit Suisse
Genesis Healthcare downgraded to Underperform from Neutral at Credit Suisse
08/11/20 Credit Suisse
Healthcare Services downgraded to Neutral from Outperform at Credit Suisse
WELL Welltower
$68.68 /

+0.15 (+0.22%)

Hot Stocks
Grocery Outlet sees FY21 EBITDA margins in line with 2019 performance » 18:36
03/02/21
03/02
18:36
03/02/21
18:36
GO

Grocery Outlet

$36.12 /

+0.19 (+0.53%)

Says first half of 2021…

Says first half of 2021 EBITDA margins to be "slightly below" their 2019 counterparts. Comments taken from Q4 earnings conference call transcript.

ShowHide Related Items >><<
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

11/18/20 Berenberg
Grocery Outlet initiated with a Buy at Berenberg
11/11/20 DA Davidson
Grocery Outlet price target lowered to $50 from $53 at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

  • 13
    Aug
  • 23
    Apr
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

Hot Stocks
Crown Castle chairman buys 7.8K shares of common stock » 18:30
03/02/21
03/02
18:30
03/02/21
18:30
CCI

Crown Castle

$153.18 /

-0.63 (-0.41%)

In a regulatory filing,…

In a regulatory filing, Crown Castle disclosed that its chairman Landis Martin bought 7,765 share of common stock on February 26th in a total transaction size of $1.23M.

ShowHide Related Items >><<
CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

01/14/21 Citi
Crown Castle upgraded to Buy from Neutral at Citi
01/11/21 BofA
BofA US 1 List changes
01/04/21 LightShed Partners
Crown Castle initiated with a Buy at LightShed Partners
12/11/20 Deutsche Bank
Crown Castle upgraded to Buy from Hold at Deutsche Bank
CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

Initiation
Certara initiated with an Overweight at Barclays » 18:28
03/02/21
03/02
18:28
03/02/21
18:28
CERT

Certara

$35.32 /

-0.72 (-2.00%)

Barclays analyst Luke…

Barclays analyst Luke Sergott initiated coverage of Certara with an Overweight rating and $40 price target. The company's portfolio of software and services provide biopharma customers with tools that can accelerate timelines and reduce costs, the analyst tells investors in a research note. Sergott add that Certara's software suite is differentiated by its scale and breadth of products and services across all aspects of a drug's life, while its market remains "underpenetrated and very fragmented".

ShowHide Related Items >><<
CERT Certara
$35.32 /

-0.72 (-2.00%)

03/02/21 Barclays
Certara initiated with an Overweight at Barclays
01/05/21 Morgan Stanley
Morgan Stanley starts Certara at Equal Weight, says fully valued
01/05/21 Morgan Stanley
Certara initiated with an Equal Weight at Morgan Stanley
01/05/21
Fly Intel: Top five analyst initiations
  • 11
    Dec
CERT Certara
$35.32 /

-0.72 (-2.00%)

CERT Certara
$35.32 /

-0.72 (-2.00%)

Initiation
Syneos Health initiated with an Equal Weight at Barclays » 18:25
03/02/21
03/02
18:25
03/02/21
18:25
SYNH

Syneos Health

$75.44 /

-0.79 (-1.04%)

Barclays analyst Luke…

Barclays analyst Luke Sergott initiated coverage of Syneos Health with an Equal Weight rating and $84 price target. Since the company's merger with InVentiv, investors have been waiting for the synergies to materialize into accelerated topline growth, the analyst tells investors in a research note. Sergott still believes that this will happen, but the transition will take time to materialize and will not be "without bumps in the road". The analyst also states that the group-low valuation for Syneos shares reflects the company's risk profile.

ShowHide Related Items >><<
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
02/22/21 Mizuho
Syneos Health price target raised to $87 from $72 at Mizuho
02/19/21 Citi
Syneos Health price target raised to $85 from $80 at Citi
12/09/20 JPMorgan
Syneos Health price target raised to $85 from $80 at JPMorgan
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

  • 01
    Mar
  • 02
    Dec
  • 16
    Sep
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

Initiation
PPD initiated with an Overweight at Barclays » 18:19
03/02/21
03/02
18:19
03/02/21
18:19
PPD

PPD

$36.00 /

+0.36 (+1.01%)

, ICLR

Icon

$172.19 /

-0.78 (-0.45%)

Barclays analyst Luke…

Barclays analyst Luke Sergott initiated coverage of PPD (PPD) with an Overweight rating and $42 price target. The analyst is positive on the company's attributes that include an accelerating growth profile, strong margin profile, and a history of capital deployment to deliver high-teens to low-20s medium term earnings-per-share growth. Sergott adds that PPD's differentiation from its closest peer Icon (ICLR) comes from its lab services and site network, which is "twice the scale".

ShowHide Related Items >><<
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

PPD PPD
$36.00 /

+0.36 (+1.01%)

03/02/21 Barclays
PPD initiated with an Overweight at Barclays
02/25/21 Deutsche Bank
PPD price target raised to $39 from $38 at Deutsche Bank
02/25/21 Citi
PPD price target raised to $42 from $40 at Citi
10/29/20 Deutsche Bank
PPD price target raised to $38 from $33 at Deutsche Bank
ICLR Icon
$172.19 /

-0.78 (-0.45%)

03/02/21 Barclays
Icon initiated with an Equal Weight at Barclays
03/02/21 Barclays
Icon initiated with an Equal Weight at Barclays
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

  • 17
    Sep
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

Periodicals
GM-backed Cruise in talks to acquire Voyage, Bloomberg reports » 18:19
03/02/21
03/02
18:19
03/02/21
18:19
GM

General Motors

$54.12 /

+1.54 (+2.93%)

Cruise, the self-driving…

Cruise, the self-driving vehicle company majority owned by General Motors, is in discussions to buy Voyage, an autonomous technology startup, Bloomberg's David Welch, Mark Bergen, and Ed Ludlow report, citing people familiar with the matter. The companies are in serious talks, though no agreement is imminent, the authors say. If a deal is reached, it would combine Cruise's engineering and software capabilities with Voyage's presence in the retirement community market, the authors note. Reference Link

ShowHide Related Items >><<
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

02/19/21 Morgan Stanley
GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley
02/18/21 Citi
General Motors price target raised to $85 from $70 at Citi
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
02/11/21 RBC Capital
General Motors price target raised to $67 from $52 at RBC Capital
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

Initiation
Iqvia initiated with an Overweight at Barclays » 18:13
03/02/21
03/02
18:13
03/02/21
18:13
IQV

Iqvia

$192.72 /

-1.69 (-0.87%)

Barclays analyst Luke…

Barclays analyst Luke Sergott initiated coverage of Iqvia with an Overweight rating and $220 price target. The analyst is citing the scale and breadth of the company's services, which differentiate the business from traditional CROs. Sergott adds that additional margin expansion opportunity from a business mix shift towards more software-oriented sales and continued capital allocation should produce a compounding high single-digit topline and a mid-to-high teens EPS growth algorithm for Iqvia, while also noting the company's recent appointment of a CFO who is "strongly focused on improving cash flow metrics".

ShowHide Related Items >><<
IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

03/02/21 Barclays
Iqvia initiated with an Overweight at Barclays
02/11/21 Truist
Iqvia price target raised to $235 from $197 at Truist
02/11/21 Wells Fargo
Iqvia price target raised to $230 from $205 at Wells Fargo
02/11/21 Baird
Iqvia price target raised to $221 from $208 at Baird
IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.